144 related articles for article (PubMed ID: 32798365)
1. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
[TBL] [Abstract][Full Text] [Related]
4. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
Todorov P; Peneva P; Tchekalarova J; Georgieva S
Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
[TBL] [Abstract][Full Text] [Related]
5. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
Todorov P; Georgieva S; Peneva P; Tchekalarova J
Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking, electrochemical and fluorimetric analysis of new caffeic and cinnamic acid-conjugated hemorphin derivatives designed as potential anticonvulsant and antinociceptive agents.
Todorov P; Georgieva S; Peneva P; Nikolov S; Rangelov M; Todorova N; Pechlivanova D; Tchekalarova J
Bioorg Chem; 2024 Feb; 143():107063. PubMed ID: 38150935
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
Fruitier I; Garreau I; Piot JM
Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
[TBL] [Abstract][Full Text] [Related]
11. LVV- and VV-hemorphins: comparative levels in rat tissues.
Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
[TBL] [Abstract][Full Text] [Related]
12. Interaction of new VV-hemorphin-5 analogues with cell membrane models.
Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
Colloids Surf B Biointerfaces; 2022 Dec; 220():112896. PubMed ID: 36270140
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
[TBL] [Abstract][Full Text] [Related]
14. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo.
Davis TP; Gillespie TJ; Porreca F
Peptides; 1989; 10(4):747-51. PubMed ID: 2587417
[TBL] [Abstract][Full Text] [Related]
15. Opioid peptides derived from hemoglobin: hemorphins.
Zhao Q; Garreau I; Sannier F; Piot JM
Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
[TBL] [Abstract][Full Text] [Related]
16. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin.
Zhao Q; Piot JM
Neuropeptides; 1997 Apr; 31(2):147-53. PubMed ID: 9179868
[TBL] [Abstract][Full Text] [Related]
17. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
[TBL] [Abstract][Full Text] [Related]
18. Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide.
Szikra J; Benyhe S; Orosz G; Darula Z; Piot JM; Fruitier I; Monory K; Hanoune J; Borsodi A
Biochem Biophys Res Commun; 2001 Mar; 281(3):670-7. PubMed ID: 11237710
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
[TBL] [Abstract][Full Text] [Related]
20. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides.
Garreau I; Zhao Q; Pejoan C; Cupo A; Piot JM
Neuropeptides; 1995 Apr; 28(4):243-50. PubMed ID: 7596489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
